Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.66 |
| ▸ | CES2 | O00748 | 1/20 | 0.58 |
| ▸ | CES1 | P23141 | 1/20 | 0.58 |
| ▸ | BCHE | P06276 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.51 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5069485 | 0.87 | PTGS2 (0.66) | ALDH1A1CYP2A6CYP3A4MAPTMEN1 | |
| SCHEMBL5069489 | 0.87 | PTGS2 (0.66) | ALDH1A1CYP2A6CYP3A4MAPTMEN1 | |
| Anisaldehyde SCHEMBL6814373 | 0.85 | ALDH1A1 (0.83) | ALDH1A1CYP2A6CES2CES1BCHE | |
| Anisaldehyde SCHEMBL20357563 | 0.85 | ALDH1A1 (0.83) | ALDH1A1CYP2A6BCHECYP3A4NFKB1 | |
| SCHEMBL15901558 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CYP2A6CES2CES1KMT2A | |
| SCHEMBL30741457 | 0.85 | CES2 (0.69) | ALDH1A1CES2CES1CYP3A4MAPT | |
| SCHEMBL68050 | 0.85 | CES2 (0.69) | ALDH1A1CES2CES1CYP3A4MAPT | |
| SCHEMBL68051 | 0.85 | CES2 (0.69) | ALDH1A1CES2CES1CYP3A4MAPT | |
| SCHEMBL31674561 | 0.85 | ALDH1A1 (0.60) | ALDH1A1CYP2A6CES2CES1KMT2A | |
| SCHEMBL9723456 | 0.85 | CES2 (0.69) | ALDH1A1CES2CES1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514689-A | Activated alkyne-tetrastyrenesulfonic acid sodium salt molecule, preparation method and application thereof in high-throughput screening of antibiotics | 南开大学 | 2023-08-01 | — | — | CN | claimed |
| CN-116514689-B | Activated alkyne-tetrastyrenesulfonic acid sodium salt molecule, preparation method and application thereof in high-throughput screening of antibiotics | 南开大学 | 2025-04-18 | — | — | CN | disclosed |
| CN-119185629-A | Embolic microsphere and preparation method thereof | 科睿驰（深圳）医疗科技发展有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-116514689-A | Activated alkyne-tetrastyrenesulfonic acid sodium salt molecule, preparation method and application thereof in high-throughput screening of antibiotics | 南开大学 | 2023-08-01 | — | — | CN | disclosed |
| US-10935552-B2 | Aie luminogens for visualization and treatment of cancer | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2021-03-02 | — | — | US | disclosed |
| CN-111909114-A | AIE luminophores for visualization and treatment of cancer | 香港科技大学 | 2020-11-10 | — | — | CN | disclosed |
| CN-107849441-B | AIE luminophores for visualization and treatment of cancer | 香港科技大学 | 2020-06-26 | — | — | CN | disclosed |
| US-20180156811-A1 | AIE LUMINOGENS FOR VISUALIZATION AND TREATMENT OF CANCER | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2018-06-07 | — | — | US | disclosed |
| US-20170168041-A1 | Polymers And Oligomers With Aggregation-Induced Emission Characteristics For Imaging And Image-Guided Therapy | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10935552-B2 | Aie luminogens for visualization and treatment of cancer | LAMP1, LAMP2, BECN1 | ALDH1A1 1573/4885CYP2A6 2391/4885CES2 2671/4885 |
| US-20170168041-A1 | Polymers And Oligomers With Aggregation-Induced Emission Characteristics For Imaging And Image-Guided Therapy | MAPT, FUS, CLTB | ALDH1A1 2973/4885CYP2A6 4582/4885CES2 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.